Jeanne F Zirkelbach (Jeanne Fourie Zirkelbach)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Locally Advanced

Tyrosine Kinase

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of patient-reported outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for locally advanced or metastatic ROS1-positive non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Huiming Xia, Brian P Booth, Yaning Wang, Chunling Fan, Vishal Bhatnagar, Paul Kluetz, Jeanne F Zirkelbach
Use of patient-reported outcomes (PRO) data to complement exposure-response analysis in early clinical cancer drug development. Journal of patient-reported outcomes 7 (1) (2023)
Elizabeth S Duke, Diana Bradford, Michelle Marcovitz, Anup K Amatya, Pallavi S Mishra-Kalyani, Emily Nguyen, Lauren S L Price, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jeffrey Kraft, Sarah E Dorff, Barbara Scepura, Maritsa Stephenson, Idara Ojofeitimi, Abhilasha Nair, Yu Han, Zivana Tezak, Steven J Lemery, Richard Pazdur, Erin Larkins, Harpreet Singh
FDA Approval Summary: Selpercatinib for the treatment of advanced RET fusion-positive solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Elizabeth S Duke, Diana Bradford, Michelle Marcovitz, Anup K Amatya, Pallavi S Mishra-Kalyani, Emily Nguyen, Lauren S L Price, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jeffrey Kraft, Sarah E Dorff, Barbara Scepura, Maritsa Stephenson, Idara Ojofeitimi, Abhilasha Nair, Yu Han, Zivana Tezak, Steven J Lemery, Richard Pazdur, Erin Larkins, Harpreet Singh
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Elizabeth S Duke, Liza Stapleford, Nicole Drezner, Anup K Amatya, Pallavi S Mishra-Kalyani, Yuan Li Shen, Kimberly Maxfield, Jeanne F Zirkelbach, Youwei Bi, Jiang Liu, Xinyuan Zhang, Hezhen Wang, Yuching Yang, Nan Zheng, Kelie Reece, Emily Wearne, Jacqueline J Glen, Idara Ojofeitimi, Barbara Scepura, Abhilasha Nair, Rama Kamesh Bikkavilli, Soma Ghosh, Reena Philip, Richard Pazdur, Julia A Beaver, Harpreet Singh, Martha Donoghue
FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Timil H Patel, Leigh Marcus, M Naomi Horiba, Martha Donoghue, Somak Chatterjee, Pallavi S Mishra-Kalyani, Robert N Schuck, Yangbing Li, Xinyuan Zhang, Jeanne F Zirkelbach, Rosane Charlab, Jiang Liu, Yuching Yang, Steven J Lemery, Richard Pazdur, Marc R Theoret, Lola A Fashoyin-Aje
FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 fusion or other rearrangement. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)